![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Cepheid’s Hepatitis B Viral Load Test Gains CE Mark
Cepheid’s Hepatitis B Viral Load Test Gains CE Mark
![](https://www.fdanews.com/ext/resources/test/Device_Images/cepheid.gif?t=1451934383&width=430)
December 27, 2018
Cepheid has received the CE Mark for a rapid molecular assay, the Xpert HBV Viral Load Test, which measures viral loads of Hepatitis B in patients.
Using Cepheid’s GeneXpert system, the test measures a patient’s HBV DNA levels via plasma or serum samples and produces quantitative results in less than an hour.
The test can be used for predicting the likely development of a disease and to measure a patient’s response to antiviral treatment.
Upcoming Events
-
21Oct